Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments
Nov 5, 2024 · Get the latest multiple sclerosis news, patient views, and caregiver perspectives from one of the largest MS communities online.
FDA OKs Phase 2 clinical trial of KYV-101 for progressive MS
Jan 5, 2024 · The U.S. Food and Drug Administration (FDA) has cleared a Phase 2 clinical trial to test Kyverna Therapeutics ‘ cell-based therapy candidate KYV-101 in people with treatment-resistant ...
Top 10 Multiple Sclerosis Stories of 2021
Jan 3, 2022 · Multiple Sclerosis News Today brought you daily coverage of the latest scientific research, advances in treatment, and clinical trials related to multiple sclerosis (MS) throughout 2021.
1-year fenebrutinib inhibits nearly all MS signs in relapsing MS trial
Sep 6, 2024 · by Lindsey Shapiro, PhD September 6, 2024. A year of treatment with the experimental BTK inhibitor fenebrutinib was safe and nearly entirely suppressed signs of disease activity, including ...
Top 10 MS stories of 2023 - Multiple Sclerosis News Today
Jan 2, 2024 · Throughout 2023, Multiple Sclerosis News Today brought consistent coverage to our readers of the latest scientific research, developments in treatment, and clinical trials for multiple sclerosis (MS).
ACTRIMS 2024: 2 treatments to aid remyelination in MS nearing...
Mar 6, 2024 · CVL-1001 inhibits EBP protein, while CVL-2001 blocks the activity of CYP51. by Marisa Wexler, MS March 6, 2024. Convelo Therapeutics is developing two experimental oral treatments to promote ...
Ocrevus, early start to aggressive treatment gaining, favored in...
Mar 9, 2023 · November 4, 2024 News by Esteban Domínguez Cerezo, MS Dosing begins in early clinical trial of Lucid-MS to protect myelin sheath November 1, 2024 News by Steve Bryson, PhD
Top 10 MS Stories of 2022 - Multiple Sclerosis News Today
Dec 30, 2022 · Multiple Sclerosis News Today brought consistent coverage of the latest scientific research, developments in treatment, and clinical trials for multiple sclerosis (MS) throughout 2022.
MS prognosis and life expectancy - Multiple Sclerosis News Today
Feb 13, 2024 · But when most patients received treatment, only about 10% converted to SPMS, and over a median of 32 years. In approximately 15% of MS patients, the disease will enter a progressive phase ...
What is multiple sclerosis? | Multiple Sclerosis News Today
Mar 14, 2022 · FAQs. Multiple sclerosis (MS) is a neurodegenerative disorder caused by the immune system mistakenly attacking the myelin sheath, a protective coating around nerve fibers. This results in ...